Respiratory management of adult patients with progressive neuromuscular disease: Non-invasive ventilation and the role of the Intensivist

Finder, 2004, Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement, Am J Respir Crit Care Med, 170, 456, 10.1164/rccm.200307-885ST Heffernan, 2006, Management of respiration in MND/ALS patients: an evidence based review, Amyotroph Lateral Scler, 7, 5, 10.1080/14660820510043235 Shahrizaila, 2007, Recommendations for respiratory care of adults with muscle disorders, Neuromuscul Disord, 17, 13, 10.1016/j.nmd.2006.09.011 Andersen, 2005, EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives, Eur J Neurol, 12, 921, 10.1111/j.1468-1331.2005.01351.x Miller, 1999, Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force, Neurology, 52, 1311, 10.1212/WNL.52.7.1311 Emery, 1991, Population frequencies of inherited neuromuscular diseases—a world survey, Neuromuscul Disord, 1, 19, 10.1016/0960-8966(91)90039-U McDonald, 1995, Profiles of neuromuscular diseases. Duchenne muscular dystrophy, Am J Phys Med Rehabil, 74, S70, 10.1097/00002060-199509001-00003 Calvert, 2006, Trends in survival from muscular dystrophy in England and Wales and impact on respiratory services, Respir Med, 100, 1058, 10.1016/j.rmed.2005.09.030 Eagle, 2002, Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation, Neuromuscul Disord, 12, 926, 10.1016/S0960-8966(02)00140-2 Vianello, 1994, Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy, Chest, 105, 445, 10.1378/chest.105.2.445 Jeppesen, 2003, The Duchenne muscular dystrophy population in Denmark, 1977–2001: prevalence, incidence and survival in relation to the introduction of ventilator use, Neuromuscul Disord, 13, 804, 10.1016/S0960-8966(03)00162-7 Meola, 2000, Myotonic dystrophies, Curr Opin Neurol, 13, 519, 10.1097/00019052-200010000-00003 Gagnon, 2007, Towards an integrative approach to the management of myotonic dystrophy type 1, J Neurol Neurosurg Psychiatry, 78, 800, 10.1136/jnnp.2006.107185 Machuca-Tzili, 2005, Clinical and molecular aspects of the myotonic dystrophies: a review, Muscle Nerve, 32, 1, 10.1002/mus.20301 Mathieu, 1999, A 10-year study of mortality in a cohort of patients with myotonic dystrophy, Neurology, 52, 1658, 10.1212/WNL.52.8.1658 de Die-Smulders, 1998, Age and causes of death in adult-onset myotonic dystrophy, Brain, 121, 1557, 10.1093/brain/121.8.1557 Chio, 2002, Early symptom progression rate is related to ALS outcome: a prospective population-based study, Neurology, 59, 99, 10.1212/WNL.59.1.99 Kimura, 2006, Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, 66, 265, 10.1212/01.wnl.0000194316.91908.8a Bensimon, 1994, A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group, N Engl J Med, 330, 585, 10.1056/NEJM199403033300901 Miller, 2007, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst Rev, CD001447 Bourke, 2006, Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial, Lancet Neurol, 5, 140, 10.1016/S1474-4422(05)70326-4 Shoesmith, 2007, Prognosis of amyotrophic lateral sclerosis with respiratory onset, J Neurol Neurosurg Psychiatry, 78, 629, 10.1136/jnnp.2006.103564 Phillips, 2001, Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy, Am J Respir Crit Care Med, 164, 2191, 10.1164/ajrccm.164.12.2103052 Hukins, 2000, Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy, Am J Respir Crit Care Med, 161, 166, 10.1164/ajrccm.161.1.9901057 Smith, 1989, Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy, Chest, 96, 1346, 10.1378/chest.96.6.1346 Barbe, 1994, Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy, Eur Respir J, 7, 1403, 10.1183/09031936.94.07081403 Bourke, 2002, Sleep and breathing in neuromuscular disease, Eur Respir J, 19, 1194, 10.1183/09031936.02.01302001a Kumar, 2007, Assessment of sleep studies in myotonic dystrophy, Chron Respir Dis, 4, 15, 10.1177/1479972306074480 Flemons, 1994, Likelihood ratios for a sleep apnea clinical prediction rule, Am J Respir Crit Care Med, 150, 1279, 10.1164/ajrccm.150.5.7952553 Flemons, 2002, Clinical practice. Obstructive sleep apnea, N Engl J Med, 347, 498, 10.1056/NEJMcp012849 Begin, 1997, Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy, Am J Respir Crit Care Med, 156, 133, 10.1164/ajrccm.156.1.9509041 Nugent, 2002, Domiciliary-assisted ventilation in patients with myotonic dystrophy, Chest, 121, 459, 10.1378/chest.121.2.459 van der Meche, 1994, Daytime sleep in myotonic dystrophy is not caused by sleep apnoea, J Neurol Neurosurg Psychiatry, 57, 626, 10.1136/jnnp.57.5.626 Ono, 1996, Neuronal loss in the medullary reticular formation in myotonic dystrophy: a clinicopathological study, Neurology, 46, 228, 10.1212/WNL.46.1.228 Giubilei, 1999, Excessive daytime sleepiness in myotonic dystrophy, J Neurol Sci, 164, 60, 10.1016/S0022-510X(99)00042-8 Ono, 1998, Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia, Neurology, 50, 535, 10.1212/WNL.50.2.535 Martinez-Rodriguez, 2003, Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness, Sleep, 26, 287, 10.1093/sleep/26.3.287 Damian, 2001, Modafinil for excessive daytime sleepiness in myotonic dystrophy, Neurology, 56, 794, 10.1212/WNL.56.6.794 MacDonald, 2002, Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy, Neurology, 59, 1876, 10.1212/01.WNL.0000037481.08283.51 Annane, 2006, Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy, Cochrane Database Syst Rev, 3, CD003218 Laberge, 2005, Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability, J Neurol Neurosurg Psychiatry, 76, 1403, 10.1136/jnnp.2004.043455 Morgan, 2005, Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis, Am J Respir Crit Care Med, 171, 269, 10.1164/rccm.200403-314OC Schmidt, 2006, Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design, Muscle Nerve, 33, 127, 10.1002/mus.20450 Czaplinski, 2006, Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population, J Neurol Neurosurg Psychiatry, 77, 390, 10.1136/jnnp.2005.072660 Lyall, 2001, Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis, Brain, 124, 2000, 10.1093/brain/124.10.2000 Lofaso, 2006, Sniff nasal inspiratory pressure: what is the optimal number of sniffs?, Eur Respir J, 27, 980, 10.1183/09031936.06.00121305 Lechtzin, 2002, Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis, Chest, 121, 436, 10.1378/chest.121.2.436 Lechtzin, 2006, Supramaximal inflation improves lung compliance in subjects with amyotrophic lateral sclerosis, Chest, 129, 1322, 10.1378/chest.129.5.1322 Bourke, 2001, Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS, Neurology, 57, 2040, 10.1212/WNL.57.11.2040 Delaubier, 1984, Traitement de l’insuffisance respiratoire chronique dans les dystrophies musculaires, 1 Leger, 1994, Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency, Chest, 105, 100, 10.1378/chest.105.1.100 Mohr, 1990, Long-term follow-up of nocturnal ventilatory assistance in patients with respiratory failure due to Duchenne-type muscular dystrophy, Chest, 97, 91, 10.1378/chest.97.1.91 Baydur, 1990, Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy, Chest, 97, 884, 10.1378/chest.97.4.884 Simonds, 1998, Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy, Thorax, 53, 949, 10.1136/thx.53.11.949 Gomez-Merino, 2002, Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing, Am J Phys Med Rehabil, 81, 411, 10.1097/00002060-200206000-00003 Gibson, 2001, Long-term ventilation for patients with Duchenne muscular dystrophy: physicians’ beliefs and practices, Chest, 119, 940, 10.1378/chest.119.3.940 Bach, 1991, Life satisfaction of individuals with Duchenne muscular dystrophy using long-term mechanical ventilatory support, Am J Phys Med Rehabil, 70, 129, 10.1097/00002060-199106000-00004 Raphael, 1994, Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French multicentre cooperative group on home mechanical ventilation assistance in Duchenne de Boulogne muscular dystrophy, Lancet, 343, 1600, 10.1016/S0140-6736(94)93058-9 Ward, 2005, Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia, Thorax, 60, 1019, 10.1136/thx.2004.037424 Vianello, 2004, Pneumothorax associated with long-term non-invasive positive pressure ventilation in Duchenne muscular dystrophy, Neuromuscul Disord, 14, 353, 10.1016/j.nmd.2004.03.002 Lyall, 2001, A prospective study of quality of life in ALS patients treated with noninvasive ventilation, Neurology, 57, 153, 10.1212/WNL.57.1.153 Piepers, 2006, Effect of non-invasive ventilation on survival, quality of life, respiratory function and cognition: a review of the literature, Amyotroph Lateral Scler, 7, 195, 10.1080/14660820500514974 Pinto, 1995, Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial, J Neurol Sci, 129, 19, 10.1016/0022-510X(95)00052-4 Aboussouan, 1997, Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis, Ann Intern Med, 127, 450, 10.7326/0003-4819-127-6-199709150-00006 Kleopa, 1999, Bipap improves survival and rate of pulmonary function decline in patients with ALS, J Neurol Sci, 164, 82, 10.1016/S0022-510X(99)00045-3 Bach, 2002, Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS, Chest, 122, 92, 10.1378/chest.122.1.92 Lo Coco, 2006, Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival, Neurology, 67, 761, 10.1212/01.wnl.0000227785.73714.64 Bushby, 2003, 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy, 7–9 June 2002, Naarden, the Netherlands, Neuromuscul Disord, 13, 166, 10.1016/S0960-8966(02)00213-4 Markham, 2006, Revising the cardiac phenotype of Duchenne muscular dystrophy, Neuromuscul Disord, 16, 699, 10.1016/j.nmd.2006.05.180 Markham, 2005, Steroid therapy and cardiac function in Duchenne muscular dystrophy, Pediatr Cardiol, 26, 768, 10.1007/s00246-005-0909-4 Duboc, 2005, Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy, J Am Coll Cardiol, 45, 855, 10.1016/j.jacc.2004.09.078 Kajimoto, 2006, Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy, Circ J, 70, 991, 10.1253/circj.70.991 Jefferies, 2005, Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy, Circulation, 112, 2799, 10.1161/CIRCULATIONAHA.104.528281 English, 2006, Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders, Dev Med Child Neurol, 48, 231, 10.1017/S0012162206000491 Pelargonio, 2002, Myotonic dystrophy and the heart, Heart, 88, 665, 10.1136/heart.88.6.665 Antonini, 2000, Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats, Neurology, 55, 1207, 10.1212/WNL.55.8.1207 Meola, 2004, Myotonic dystrophy type 2 and related myotonic disorders, J Neurol, 251, 1173, 10.1007/s00415-004-0590-1 Desport, 1999, Nutritional status is a prognostic factor for survival in ALS patients, Neurology, 53, 1059, 10.1212/WNL.53.5.1059 Pessolano, 2003, Nutritional assessment of patients with neuromuscular diseases, Am J Phys Med Rehabil, 82, 182, 10.1097/01.PHM.0000052588.28912.A4 Munn, 2005, Estimate of daily calorie needs for a neuromuscular disease patient receiving noninvasive ventilation, Am J Phys Med Rehabil, 84, 639, 10.1097/01.phm.0000171011.83756.34 Pane, 2006, Feeding problems and weight gain in Duchenne muscular dystrophy, Eur J Paediatr Neurol, 10, 231, 10.1016/j.ejpn.2006.08.008 Gonzalez-Bermejo, 2005, Resting energy expenditure in Duchenne patients using home mechanical ventilation, Eur Respir J, 25, 682, 10.1183/09031936.05.00031304 Desport, 2001, Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis, Am J Clin Nutr, 74, 328, 10.1093/ajcn/74.3.328 Heffernan, 2004, Nutritional management in MND/ALS patients: an evidence based review, Amyotroph Lateral Scler Other Motor Neuron Disord, 5, 72, 10.1080/14660820410020349 Boitano, 2001, Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS, Neurology, 56, 413, 10.1212/WNL.56.3.413 Gregory, 2002, Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival, Neurology, 58, 485, 10.1212/WNL.58.3.485 Cameron, 2002, Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders, Curr Opin Clin Nutr Metab Care, 5, 631, 10.1097/00075197-200211000-00005 Bach, 1994, Update and perspective on noninvasive respiratory muscle aids. Part 2: the expiratory aids, Chest, 105, 1538, 10.1378/chest.105.5.1538 Suarez, 2002, Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease, Am J Phys Med Rehabil, 81, 506, 10.1097/00002060-200207000-00007 Bach, 1997, Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy, Chest, 112, 1024, 10.1378/chest.112.4.1024 Sancho, 2007, Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis, Am J Respir Crit Care Med, 175, 1266, 10.1164/rccm.200612-1841OC Tzeng, 2000, Prevention of pulmonary morbidity for patients with neuromuscular disease, Chest, 118, 1390, 10.1378/chest.118.5.1390 Mendell, 1989, Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy, N Engl J Med, 320, 1592, 10.1056/NEJM198906153202405 Balaban, 2005, Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect, Am J Phys Med Rehabil, 84, 843, 10.1097/01.phm.0000184156.98671.d0 Biggar, 2006, Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade, Neuromuscul Disord, 16, 249, 10.1016/j.nmd.2006.01.010 Bonifati, 2000, A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy, Muscle Nerve, 23, 1344, 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F Bushby, 2004, Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids, 2–4 April 2004, Naarden, The Netherlands, Neuromuscul Disord, 14, 526, 10.1016/j.nmd.2004.05.006 Campbell, 2003, Deflazacort for the treatment of Duchenne Dystrophy: a systematic review, BMC Neurol, 3, 7, 10.1186/1471-2377-3-7 Manzur, 2004, Glucocorticoid corticosteroids for Duchenne muscular dystrophy, Cochrane Database Syst Rev, CD003725 Moxley, 2005, Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Neurology, 64, 13, 10.1212/01.WNL.0000148485.00049.B7 Pradhan, 2006, Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation, J Neurol, 253, 1309, 10.1007/s00415-006-0212-1 Griggs, 1991, Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group, Arch Neurol, 48, 383, 10.1001/archneur.1991.00530160047012 Quinlivan, 2005, Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16, 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention, Neuromuscul Disord, 15, 72, 10.1016/j.nmd.2004.09.009 Nava, 2007, End-of-life decision-making in respiratory intermediate care units: a European survey, Eur Respir J, 30, 156, 10.1183/09031936.00128306 Toussaint, 2006, Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients, Eur Respir J, 28, 549, 10.1183/09031936.06.00004906 Lofaso, 2006, Ventilatory assistance in patients with Duchenne muscular dystrophy, Eur Respir J, 28, 468, 10.1183/09031936.06.00059906 Bach, 2007, Tracheostomy tubes are not needed for Duchenne muscular dystrophy, Eur Respir J, 30, 179, 10.1183/09031936.00156806 Lofaso, 2007, From the authors, Eur Respir J, 30, 180, 10.1183/09031936.00027307 Cazzolli, 1996, Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation, J Neurol Sci, 139, 123, 10.1016/0022-510X(96)00099-8 Bach, 1993, A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver, Chest, 104, 1702, 10.1378/chest.104.6.1702 Gilgoff, 1989, Patient and family participation in the management of respiratory failure in Duchenne's muscular dystrophy, Chest, 95, 519, 10.1378/chest.95.3.519 Rubin, 2007, Mucolytics, expectorants, and mucokinetic medications, Respir Care, 52, 859 Webster, 1999, Metabolic alkalosis in the critically ill, Crit Rev Clin Lab Sci, 36, 497, 10.1080/10408369991239286 Hockings, 1993, Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport, J Clin Endocrinol Metab, 76, 1433, 10.1210/jc.76.6.1433 2002, Neurol India, 50, 105 Cai, 2003, Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients, Nutrition, 19, 229, 10.1016/S0899-9007(02)01064-X Reid, 2006, Frequency of under- and overfeeding in mechanically ventilated ICU patients: causes and possible consequences, J Hum Nutr Diet, 19, 13, 10.1111/j.1365-277X.2006.00661.x Stone, 2000, Bedside placement of postpyloric feeding tubes, AACN Clin Issues, 11, 517, 10.1097/00044067-200011000-00005 Marinella, 2003, The refeeding syndrome and hypophosphatemia, Nutr Rev, 61, 320, 10.1301/nr.2003.sept.320-323 Kane, 2002, Clinical outcomes of critical illness polyneuropathy, Pharmacotherapy, 22, 373, 10.1592/phco.22.5.373.33199 Wagner, 2001, Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations, Ann Neurol, 49, 706, 10.1002/ana.1023